Inari Medical EBITDA 2019-2024 | NARI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Inari Medical ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Inari Medical ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$196.3B
Intuitive Surgical (ISRG)	$195.1B
Alcon (ALC)	$42.4B
Edwards Lifesciences (EW)	$41.6B
IQVIA Holdings (IQV)	$36.6B
IDEXX Laboratories (IDXX)	$34.2B
DexCom (DXCM)	$28.4B
Waters (WAT)	$22.2B
STERIS (STE)	$21.2B
SONOVA HOLDING (SONVY)	$20.8B
Hologic (HOLX)	$18.3B
Fresenius Medical Care AG KGaA (FMS)	$13B
Sysmex ADR (SSMXY)	$12.9B
Globus Medical (GMED)	$11.5B
Penumbra (PEN)	$9.4B
Masimo (MASI)	$9.3B
Teleflex (TFX)	$8.9B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$4.9B
Integer Holdings (ITGR)	$4.6B
Veracyte (VCYT)	$3.1B
LivaNova (LIVN)	$2.8B
TransMedics (TMDX)	$2.6B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.2B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.8B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.4B
Artivion (AORT)	$1.2B